Deepak Voora

Evaluation of the PharmGKB Knowledge Base as a Resource for Efficiently Assessing the Clinical Validity and Utility of Pharmacogenetic Assays

Kensaku Kawamoto, David F. Lobach, Lori A. Orlando, 2009, AMIA.

The long and winding road to warfarin pharmacogenetic testing.

Geoffrey S Ginsburg, Deepak Voora, G. Ginsburg, 2010, Journal of the American College of Cardiology.

Genetic-based dosing in orthopedic patients beginning warfarin therapy.

Deepak Voora, Elena Deych, Paul E Milligan, 2007, Blood.

Prospective dosing of warfarin based on cytochrome P-450 2C9 genotype

Howard L McLeod, Deepak Voora, Paul E Milligan, 2005, Thrombosis and Haemostasis.

A Host-Based RT-PCR Gene Expression Signature to Identify Acute Respiratory Viral Infection

Lawrence Carin, Geoffrey S Ginsburg, Alfred O Hero, 2013, Science Translational Medicine.

Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.

Joshua C Denny, Shuko Harada, James Willig, 2018, JACC. Cardiovascular interventions.

The pharmacogenetics of coumarin therapy.

Howard L McLeod, Deepak Voora, D. Voora, 2005, Pharmacogenomics.